Your browser doesn't support javascript.
loading
NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies.
Kokuryo, Toshio; Yokoyama, Yukihiro; Yamaguchi, Junpei; Tsunoda, Nobuyuki; Ebata, Tomoki; Nagino, Masato.
Afiliação
  • Kokuryo T; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan kokuryoh@med.nagoya-u.ac.jp.
  • Yokoyama Y; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamaguchi J; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tsunoda N; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ebata T; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nagino M; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Anticancer Res ; 39(5): 2251-2258, 2019 May.
Article em En | MEDLINE | ID: mdl-31092416

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Quinases Relacionadas a NIMA / Neoplasias Limite: Animals / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Quinases Relacionadas a NIMA / Neoplasias Limite: Animals / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Grécia